NVTG Symposium: come and discuss ethical dilemmas in global health

How can we deal with ethical dilemmas in global health? Come and join the discussion on November 9th with Dr. Ann Phoya (President of the Association of Malawian Midwives) and others at the NTVG Symposium ‘Human resources, research and rights’ in De Rode Hoed in Amsterdam. Wemos will be co-organizing the event, together with NVTG, Uniting Streams and TROIE.

The symposium will focus on the ethical dilemmas that global health experts often face. How can we ensure a fair distribution of scarce resources for health? How can we counterbalance the recruitment of health professionals from low resource settings, whilst respecting people’s right to migrate? Experts, academics and organizations will discuss this and hold presentations, workshops and debates. Wemos will hold an interactive workshop, Dr, Ann Phoya – whom we interviewed a while ago – will talk about how Malawi deals with HIV and maternal mortality, and Dr. Rieke van der Graaf (UCM) and Dr. Anant Bhan (India) will reflect on ethics and human subjects research.


You’re most welcome to attend the symposium, which is open to both NVTG and non-NVTG members. Registration is possible via this link. The Dutch Association for Tropical Medicine and International Health care, or NVTG, is an association for global health professionals and tropical physicians in the Netherlands.


Programme and location

Date: Friday November 9th 2018

Location: De Rode Hoed, Amsterdam

Partners: Uniting Streams, TROIE, Wemos


Find more information here and on Facebook


Recent News items

This week: 72nd World Health Assembly


From May 20-28, the 72nd session of the World Health Assembly (WHA) will take place in Geneva, Switzerland. Each year, senior health officials from the World Health Organization’s (WHO) Member States gather there to discuss the WHO’s progress, new goals and global health agenda and challenges. Wemos will be present as well as a civil society organization and attend sessions on Financing for Health, the Global Action Plan for Healthy Lives and Well-being and Access to Medicines.

Continue reading

Overpriced drugs developed with tax money


Research shows major Dutch public investments in drug development


Overpriced, a report published today jointly by The Centre for Research on Multinational Corporation (SOMO) and Wemos, examines the extent of Dutch public funding of drug development, through donations, loans and/or investments. This funding occurs both directly by financing development of new medicines, and indirectly through investments made into biotech companies, but channelled through universities, public research bodies, and national and regional investment funds. The report reveals, however, that because no conditions are set on these investments, the Government loses its chance to curb subsequent high drug prices.

Continue reading